Open Menu
0
Give in Honor or Memory
Donate Now
Home
About Us
About NFCR
Our Team & Culture
Research
Focus Areas
Meet Our Scientists
Featured Programs
GBM AGILE
AIM-HI Translational Research Initiative
NFCR Global Summit
Szent-Györgyi Prize
Cancer Information
Cancer Types & Key Facts
Detection Guidelines
Prevention & Lifestyle
Caregiver Hub
Cancer Diagnosis Series
Blogs & News
Blogs
Press releases
Get Involved
Volunteer
Daffodils & Diamonds
Youth Fundraising
Community Ambassadors
Receive E-News
Donate
Ways to Give
Tribute Giving
Gifts for a Cure Shop
Immunotherapy
All Things Cancer Episode #12: Can CAR-T Therapy Finally Conquer Solid Tumors?
October 29, 2025
David Webber
Blog
...
Read more
All Things Cancer Episode #10: Harnessing the Immune System with Drew Pardoll
September 9, 2025
David Webber
Blog
...
Read more
All Things Cancer Episode #4: Dr. James Allison on Immunotherapy
April 7, 2025
NFCR
Blog
...
Read more
Two NFCR-Supported Researchers Help Identify Cells That Naturally Fight Cancer
February 11, 2025
Julia Felts Foster
Blog
...
Read more
NFCR-Supported Research Team Working On CAR-T Immunotherapy For Pancreatic Cancer
September 13, 2022
Michael Wang, M.D., Ph.D.
Blog
...
Read more
Rectal Cancers Vanished After Immunotherapy Treatment
August 30, 2022
Michael Wang, M.D., Ph.D.
Blog
...
Read more
5 Tips to Help Prevent Melanoma
August 23, 2022
Michael Wang, M.D., Ph.D.
Blog
...
Read more
New Drug Makes Unresectable or Metastatic Ocular Cancer Treatable
March 1, 2022
Michael Wang, M.D., Ph.D.
Blog
...
Read more
New Research Sets Physical Activity Goals for Cancer Prevention
February 22, 2022
Guest
Blog
,
Cancer-Fighting Lifestyle
...
Read more
New Treatment with Combined Immunotherapies is Effective for Drug Resistant Metastatic Lung Cancer
September 20, 2021
Michael Wang, M.D., Ph.D.
Blog
...
Read more
1
2
3
Strategic Media Partner
×
Your ticket for the: New Treatment with Combined Immunotherapies is Effective for Drug Resistant Metastatic Lung Cancer
Title
New Treatment with Combined Immunotherapies is Effective for Drug Resistant Metastatic Lung Cancer
USD